Expression profiling of purified normal human luminal and myoepithelial breast cells: identification of novel prognostic markers for breast cancer.
暂无分享,去创建一个
Alan Mackay | Antonio Cossu | Giuseppe Palmieri | Chris Jones | Anita Grigoriadis | Sunil R Lakhani | Jorge S Reis-Filho | S. Lakhani | J. Reis-Filho | A. Grigoriadis | Chris Jones | A. Mackay | A. Cossu | L. Fulford | T. Dexter | S. Davies | K. Bulmer | E. Ford | S. Parry | M. Budroni | G. Palmieri | A. Neville | M. O'hare | Tim Dexter | Laura Fulford | Susan Davies | Karen Bulmer | Emily Ford | Suzanne Parry | Mario Budroni | A Munro Neville | Michael J O'Hare | Chris Jones
[1] S. Lakhani,et al. CGH analysis of ductal carcinoma of the breast with basaloid/myoepithelial cell differentiation , 2001, British Journal of Cancer.
[2] S. Hirohashi,et al. Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones. , 1999, Human pathology.
[3] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[4] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[5] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[6] G. Landes,et al. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer. , 1999, Cancer research.
[7] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[8] S. Dudoit,et al. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. , 2002, Nucleic acids research.
[9] E. Lane,et al. Characterization in vitro of luminal and myoepithelial cells isolated from the human mammary gland by cell sorting. , 1991, Differentiation; research in biological diversity.
[10] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[11] B. Gusterson,et al. Distribution of myoepithelial cells and basement membrane proteins in the normal breast and in benign and malignant breast diseases. , 1982, Cancer research.
[12] J. Marks,et al. A SAGE (serial analysis of gene expression) view of breast tumor progression. , 2001, Cancer research.
[13] M. Loda,et al. Growth factor requirements and basal phenotype of an immortalized mammary epithelial cell line. , 2002, Cancer research.
[14] A. Raz,et al. Galectin-3 enhances cyclin D1 promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells , 2002, Oncogene.
[15] M J O'Hare,et al. Proteomic definition of normal human luminal and myoepithelial breast cells purified from reduction mammoplasties. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[16] M. Castellazzi,et al. Transcriptional upregulation of SPARC, in response to c-Jun overexpression, contributes to increased motility and invasion of MCF7 breast cancer cells , 2002, Oncogene.
[17] R. Tibshirani,et al. Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome , 2022 .
[18] R. Nagle,et al. Coexpression patterns of vimentin and glial filament protein with cytokeratins in the normal, hyperplastic, and neoplastic breast. , 1990, The American journal of pathology.
[19] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[20] S. Davies,et al. An immunomagnetic separation method using superparamagnetic (MACS) beads for large-scale purification of human mammary luminal and myoepithelial cells. , 1994, Epithelial cell biology.
[21] K. Hemminki,et al. Loss of heterozygosity in tumour-adjacent normal tissue of breast and bladder cancer. , 2001, European journal of cancer.
[22] A. Thor,et al. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas , 1996, Science.
[23] E. Lander,et al. A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.
[24] R. Salunga,et al. Gene expression profiles of human breast cancer progression , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] Jason E. Stewart,et al. Minimum information about a microarray experiment (MIAME)—toward standards for microarray data , 2001, Nature Genetics.
[26] V. Castronovo,et al. DECREASED EXPRESSION OF GALECTIN‐3 IS ASSOCIATED WITH PROGRESSION OF HUMAN BREAST CANCER , 1996, The Journal of pathology.
[27] Yudong D. He,et al. A Gene-Expression Signature as a Predictor of Survival in Breast Cancer , 2002 .
[28] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] Allison Jones,et al. cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells , 2003, Oncogene.
[30] J. Kononen,et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens , 1998, Nature Medicine.
[31] M. Stratton,et al. Genetic alterations in ‘normal’ luminal and myoepithelial cells of the breast , 1999, The Journal of pathology.
[32] S. Hirohashi,et al. Large, central acellular zones indicating myoepithelial tumor differentiation in high-grade invasive ductal carcinomas as markers of predisposition to lung and brain metastases. , 2000, The American journal of surgical pathology.
[33] C. Perou,et al. Molecular portraits and the family tree of cancer , 2002, Nature Genetics.
[34] L. Puett,et al. Expression of basal and luminal epithelium-specific keratins in normal, benign, and malignant breast tissue. , 1988, Journal of the National Cancer Institute.
[35] E. Lane,et al. Basal cell-specific and hyperproliferation-related keratins in human breast cancer. , 1991, The American journal of pathology.
[36] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[37] E. Lane,et al. Keratin Expression in the Mammary Gland , 1987 .